Rothschild & Co Asset Management US’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$3.04M Sell
266,132
-18,095
-6% -$268K 0.05% 211
2022
Q3
$4.84M Sell
284,227
-391
-0.1% -$8.39K 0.08% 179
2022
Q2
$6.11M Buy
+284,618
New +$7.89M 0.09% 163

Other funds holding CDNA

Rothschild & Co Asset Management US's CDNA Position: Q4 2022 in Review

Rothschild & Co Asset Management US reduced its CareDx (CDNA) stake by 6.4% in Q4 2022, selling an estimated $268K and leaving 266,132 shares worth $3.04M. The position accounts for 0.05% of the portfolio, ranked #211.

Rothschild & Co Asset Management US first reported a position in CDNA in Q2 2022 and has held it in 3 quarters since. The position peaked at $6.11M in Q2 2022. 168 funds tracked by Wall St. Rank hold CDNA as of Q4 2022.

  • Rothschild & Co Asset Management US held 266,132 shares of CareDx worth $3.04M as of Q4 2022.
  • Rothschild & Co Asset Management US sold 18,095 CareDx shares in Q4 2022, an estimated $268K.
  • CareDx made up 0.05% of Rothschild & Co Asset Management US's portfolio in Q4 2022, its #211 holding.
  • Rothschild & Co Asset Management US first reported a position in CareDx in Q2 2022 and has held it in 3 quarters since.
  • Rothschild & Co Asset Management US's CareDx position peaked at $6.11M in Q2 2022.
  • 168 funds tracked by Wall St. Rank held CareDx as of Q4 2022.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2022, filed 14 Feb 2023.